Pfizer, Moderna race to roll out new boosters as Covid-19 becomes endemic

Moving forward, Pfizer and Moderna will roll out new booster shots and vaccines for younger age groups to support revenues. PHOTO: REUTERS
New: Gift this subscriber-only story to your friends and family

SINGAPORE - While US drugmakers like Pfizer and Moderna made a killing from Covid-19 mRNA vaccine sales last year, sustaining similar volumes this year will be a challenge as more parts of the world become fully vaccinated.

At their 2021 results briefings last month, both drugmakers said they expect Covid-19 to enter the endemic phase this year, but regular booster shots will be needed to protect the public from new infections.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.